Dama, Azzubayn A.

HRN: 21-45-57  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/13/2022
06/20/2022
IV DRIP
250mg
Q6H
Sepsis, Abscess Right Mastoid Area
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: